{
    "clinical_study": {
        "@rank": "141062", 
        "arm_group": [
            {
                "arm_group_label": "FloSeal group", 
                "arm_group_type": "Experimental", 
                "description": "This group will undergo appropriate cancer surgery for each patient with pelvic lymph node dissection +/- para-aortic lymph node dissection. At the completion of lymph node dissection, 2 vials of Floseal will be applied to each lymph node area."
            }, 
            {
                "arm_group_label": "No FloSeal group", 
                "arm_group_type": "No Intervention", 
                "description": "All surgical procedures of control group is the same with study group except that Floseal is not applicated in control group."
            }
        ], 
        "brief_summary": {
            "textblock": "To compare the incidence of lymphocele and lymphatic ascites between patient who use versus\n      who do not use FloSeal during lymph node dissection"
        }, 
        "brief_title": "Efficacy Study of FloSeal for Prevention of Lymphocele After Lymphadenectomy for Gynecologic Cancer", 
        "condition": [
            "Gynecologic Cancer", 
            "Cervical Cancer", 
            "Endometrial Cancer", 
            "Ovarian Cancer", 
            "Fallopian Tubal Cancer"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Endometrial Neoplasms", 
                "Uterine Cervical Neoplasms", 
                "Lymphocele", 
                "Ovarian Neoplasms"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Histologically confirmed primary cancer of the uterine cervix, uterine corpus, ovary,\n             and fallopian tube\n\n          -  FIGO stage Cervical cancer: FIOG stage IA2-IIA2 Uterine cancer: FIGO stage I-III\n             Ovarian and fallopian tubal cancer: FIGO stage I-IIIB\n\n          -  Patients who undergoing surgery including pelvic and/or para-aortic lymph node\n             dissection\n\n          -  Patients with adequate bone marrow, renal and hepatic function:\n\n        WBC > 3,000 cells/mcl Platelets >100,000/mcl Creatinine <2.0 mg/dL Bilirubin <1.5 x normal\n        and SGOT or SGPT <3 x normal\n\n          -  American Society of Anesthesiology Physical Status 0-1\n\n          -  Performance status of ECOG 0-2\n\n          -  Patient must be suitable candidates for surgery\n\n          -  Patients who have signed an approved Informed Consent\n\n        Exclusion Criteria:\n\n          -  Patients with a history of pelvic or abdominal radiotherapy;\n\n          -  Patients who are pregnant\n\n          -  Patients with contraindications to surgery;\n\n          -  Patients who are unfit for Surgery: serious concomitant systemic disorders\n             incompatible with the study (at the discretion of the investigator);\n\n          -  Patient's compliance and geographic proximity that do not allow adequate follow-up.\n\n          -  Patients who undergo only lymph node sampling"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 3, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01679483", 
            "org_study_id": "FloSeal-LND"
        }, 
        "intervention": {
            "arm_group_label": "FloSeal group", 
            "description": "At the completion of lymph node dissection, 2 vials of Floseal will be applied to each lymph node area.", 
            "intervention_name": "FloSeal application", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "September 3, 2012", 
        "location": {
            "contact": {
                "email": "jhnam@amc.seoul.kr", 
                "last_name": "Joo-Hyun Nam, M.D., Ph.D.", 
                "phone": "82-2-3010-3633"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "138-736"
                }, 
                "name": "Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "THE ROLE OF FLOSEAL IN THE PREVENTION OF LYMPHOCELE AND LYMPHATIC ASCITES AFTER LYMPH NODE DISSECTION FOR GYNECOLOGIC CANCER: A RANDOMIZED CONTROLLED TRIAL", 
        "overall_contact": {
            "email": "jhnam@amc.seoul.kr", 
            "last_name": "Joo-Hyun Nam, M.D., Ph.D.", 
            "phone": "82-2-3010-3633"
        }, 
        "overall_official": {
            "affiliation": "Asan Medical Center", 
            "last_name": "Joo-Hyun Nam, M.D., Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Asan Medical Center Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Incidence of lymphocele an lymphatic ascites", 
            "safety_issue": "No", 
            "time_frame": "within 1 year after surgery"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01679483"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Asan Medical Center", 
            "investigator_full_name": "Joo-Hyun Nam", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Time interval from surgery to removal of closed drain system", 
                "safety_issue": "No", 
                "time_frame": "with 2 weeks after surgery"
            }, 
            {
                "measure": "Postoperative drain amount", 
                "safety_issue": "No", 
                "time_frame": "with 2 weeks after surgery"
            }, 
            {
                "measure": "Postoperative hospital stay", 
                "safety_issue": "No", 
                "time_frame": "within 2 weeks after surgery"
            }, 
            {
                "measure": "Postoperative bleeding incidence", 
                "safety_issue": "Yes", 
                "time_frame": "within 2 weeks after surgery"
            }, 
            {
                "measure": "Postoperative complication incidence", 
                "safety_issue": "Yes", 
                "time_frame": "within 1 month after surgery"
            }, 
            {
                "measure": "Quality of life", 
                "safety_issue": "No", 
                "time_frame": "within 1 year after surgery"
            }, 
            {
                "measure": "2-year disease free survival and overall survival", 
                "safety_issue": "No", 
                "time_frame": "2 years after surgery"
            }
        ], 
        "source": "Asan Medical Center", 
        "sponsors": {
            "collaborator": {
                "agency": "Baxter Healthcare Corporation", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Asan Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "September 2012"
    }
}